K Huebner
Impact in
- Toxicology top 2%
- Molecular Biology top 5%
- Cancer therapeutics and mechanisms
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
- Chromatin Remodeling and Cancer
Papers in
- Genetics 5
- Genetics and Neurodevelopmental Disorders 7
- Chronic Lymphocytic Leukemia Research 4
- Genomic variations and chromosomal abnormalities 4
- Virus-based gene therapy research 3
-
- Chronic Myeloid Leukemia Treatments 4
- Co-authors
- Carlo M. CroceC M CroceLutz GissmannErich M. SchwarzMatthias DürstTor KnutsenLeroy F. LiuJ C Wang
- Journals
- Proceedings of the National Academy of Sciences (10 papers)Cytogenetic and Genome Research (2 papers)Cancers (2 papers)Traffic (1 paper)Scientific Reports (1 paper)
- Partner nations
- United StatesGermanyPoland
In The Last Decade
K Huebner
42 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 94
- Toxicology 97
- Molecular Biology 1.7k
- Oncology 643
- Genetics 623
- Immunology and Allergy 116
Countries citing papers authored by K Huebner
This map shows the geographic impact of K Huebner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Huebner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Huebner more than expected).
Fields of papers citing papers by K Huebner
This network shows the impact of papers produced by K Huebner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Huebner. The network helps show where K Huebner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside K Huebner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 13 | |
| 3 | 2023 | 3 | |
| 4 | 2021 | 10 | |
| 5 | 2019 | 43 | |
| 6 | 2019 | 57 | |
| 7 | 2015 | 8 | |
| 8 | 2009 | 1 | |
| 9 | Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer. | 2001 | 89 |
| 10 | Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells. | 2001 | 87 |
| 11 | 2001 | 17 | |
| 12 | Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas. | 1999 | 40 |
| 13 | Loss of FHIT expression in acute lymphoblastic leukemia. | 1999 | 18 |
| 14 | Absence or reduction of Fhit expression in most clear cell renal carcinomas. | 1998 | 69 |
| 15 | Structure and expression of the human FHIT gene in normal and tumor cells. | 1997 | 173 |
| 16 | Aberrant FHIT transcripts in Merkel cell carcinoma. | 1996 | 65 |
| 17 | 1992 | 8 | |
| 18 | 1991 | 14 | |
| 19 | 1987 | 292 | |
| 20 | 1986 | 83 |
About K Huebner
K Huebner is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Genetics and Molecular Biology, having authored 43 papers that have together received 2.4k indexed citations. Recurring topics across this work include Genetics and Neurodevelopmental Disorders (7 papers), RNA modifications and cancer (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Genomic variations and chromosomal abnormalities (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Virus-based gene therapy research (3 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Toxicology (97 citations), Molecular Biology (1.7k citations), Oncology (643 citations), Genetics (623 citations) and Immunology and Allergy (116 citations). K Huebner has collaborated with scholars based in United States, Germany and Poland. Frequent co-authors include Carlo M. Croce, C M Croce, Lutz Gissmann, Erich M. Schwarz, Matthias Dürst, Tor Knutsen, Leroy F. Liu, J C Wang, Jacqueline Whang‐Peng and K M Tewey. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cytogenetic and Genome Research, Cancers, Traffic and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.